Cemtrex (CETX) had the highest return between 2002 and 2008 by a US stock, returning 102,360,057.8%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Cemtrex (CETX) | 2002-2008 | 102,360,057.75% |
Future Fintech (FTFT) | 2002-2008 | 7,999,900% |
InterContinental Hotels Group PLC ADR (IHG) | 2002-2008 | 5,519,600% |
India Globalization Capital (IGC) | 2002-2008 | 1,616,566.67% |
National Grid PLC ADR (NGG) | 2002-2008 | 1,237,321.43% |
Natwest (NWG) | 2002-2008 | 953,400% |
Hirequest (HQI) | 2002-2008 | 935,500% |
Taoping (TAOP) | 2002-2008 | 863,957.6% |
Houston American Energy (HUSA) | 2002-2008 | 853,743.24% |
Northern Oil & Gas (NOG) | 2002-2008 | 838,607.69% |
Enveric Biosciences (ENVB) | 2002-2008 | 652,073.98% |
Know Labs (KNW) | 2002-2008 | 534,224.43% |
NextTrip (NTRP) | 2002-2008 | 159,900% |
Ring Energy (REI) | 2002-2008 | 146,566.67% |
OPTIMIZERx (OPRX) | 2002-2008 | 124,100% |
Ocean Power Technologies (OPTT) | 2002-2008 | 74,233.33% |
Alto Ingredients (ALTO) | 2002-2008 | 70,219.63% |
Perspective Therapeutics (CATX) | 2002-2008 | 66,566.67% |
Lixte Biotechnology (LIXT) | 2002-2008 | 55,965.57% |
PharmaCyte Biotech (PMCB) | 2002-2008 | 12,988.89% |
NetEase (NTES) | 2002-2008 | 11,694.24% |
NanoViricides (NNVC) | 2002-2008 | 11,240% |
Gyre Therapeutics (GYRE) | 2002-2008 | 7,448.45% |
TherapeuticsMD (TXMD) | 2002-2008 | 7,439.95% |
Monster Beverage (MNST) | 2002-2008 | 6,221.72% |
